Novonesis (NSIS) Status Update summary
Event summary combining transcript, slides, and related documents.
Status Update summary
11 Jan, 2026Business overview and growth drivers
Energy is a key segment, representing about half of the Agriculture, Energy, and Tech group, which is 35-36% of turnover.
Growth is driven by rising fuel demand, decarbonization, chemical replacement, and energy independence.
Diversification spans end markets (e.g., DDGS, corn oil, sustainable aviation fuel), feedstocks (grain, vegetable oils, biomass), and geographies (North America, Latin America, India).
North America remains the largest market, but Latin America and India are showing strong growth.
Innovation and market diversification
Revenue sources have shifted from being U.S.-centric and enzyme-only to more diversified drivers, including geography, end markets, and feedstocks.
Biomass-based ethanol and enzyme-based biodiesel are emerging areas with significant upside, especially in Brazil and India.
Enzyme-based solutions now have about 10% penetration in the biodiesel market, with mandates in Brazil, India, Malaysia, South Korea, and Japan supporting growth.
Innovation focuses on customer intimacy, tailored solutions, and continuous performance improvements (1-2% annually).
New yeast products, such as Innova Eclipse, are being launched to further enhance efficiency.
Sustainable aviation fuel (SAF) and future opportunities
Liquid sustainable fuels are critical for decarbonizing transport, with biofuels expected to grow through 2030-2035.
SAF market development is expected in phases: initial HEFA dominance, followed by alcohol-to-jet (ethanol-to-jet) and advanced fuels.
Biosolutions can play roles in pretreatment, ethanol-to-jet conversion, and supplying biogenic CO2 for e-fuels.
If SAF captures 30% of aviation fuel, ethanol-to-jet could represent 7-27 billion gallons, a significant share of the current 30 billion gallon global ethanol market.
Regulatory clarity, incentives, and technology deployment are key for scaling SAF.
Latest events from Novonesis
- 7% organic sales growth and 37.1% EBITDA margin in 2025; 2026 outlook remains strong.NSIS
Q4 202518 Mar 2026 - 9% organic sales growth YTD 2024; full-year outlook raised to upper end of 7-8%.NSIS
Q3 202416 Feb 2026 - Upgraded 2024 outlook, 6%-8% growth, and margin expansion driven by synergies and innovation.NSIS
CMD 20243 Feb 2026 - 7% organic sales growth, margin gains, and innovation led to a raised 2024 outlook.NSIS
Q2 202423 Jan 2026 - Full control of animal biosolutions value chain drives growth, innovation, and margin gains.NSIS
M&A Announcement8 Jan 2026 - Double-digit Q1 growth, margin expansion, and a major acquisition support a strong outlook.NSIS
Q1 20258 Jan 2026 - 8% organic growth and 36.1% margin in 2024; 2025 outlook strong with synergies and innovation.NSIS
Q4 20247 Jan 2026 - Strong growth, integration, and sustainability marked the year; all AGM proposals were approved.NSIS
AGM 20257 Jan 2026 - Strong H1 growth, margin gains, and robust 2030 targets amid innovation and market expansion.NSIS
Q2 2025 & Strategy Update23 Nov 2025